Peninsula Pharmaceuticals

Calixa Therapeutics

This biopharmaceutical company develops novel antibiotics to treat serious infections caused by multi-drug-resistant pathogens for hospital patients.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

Iterum Therapeutics

This pharmaceutical company develops and commercialises oral and intravenous antibiotics for patients with multi-drug resistant infections, including urinary tract infections.

Arpida

This company develops antimicrobial drugs and broad-spectrum antibiotics to treat patients with severe bacterial infections requiring hospital treatment.

C10 PHARMA

This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.

TXN Systems

This pharmaceutical company develops a novel class of antibiotics to treat multidrug-resistant urinary tract infections in patients.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.